Medical devices, healthcare technology and the business of care
PMA approval · P960058

CLARION MULTI-STRATEGY COCHLEAR IMPLANT

Advanced Bionics · Decision date Jun 26, 1997

FDA DECISIONP960058

What did the FDA approve?

FDA records P960058 as an original PMA application. The recorded decision is approval, dated Jun 26, 1997.

FDA approval order statement

APPROVAL FOR THE CLARION MULTI-STRATEGY COCHLEAR IMPLANT. THE DEVICE IS INTENDED TO RESTORE A LEVEL OF AUDITORY SENSATION TO CHILDREN WITH PROFOUND SENSORINEURAL DEAFNESS VIA ELECTRICAL STIMULATION OF THE AUDITORY NERVE. CLARION IS INDICATED FOR THE FOLLOWING: 1)CHILDREN, 2 THROUGH 17 YEARS OF AGE. IF X-RAYS DEMONSTRATE EVIDENCE OF OSSIFICATION, CHILDREN AS YOUNG AS 18 MONTHS MAY BE IMPLANTED; 2)PROFOUND, BILATERAL SENSORINEURAL DEAFNESS; 3)UNDERGONE OR BE WILLING TO UNDERGO A HEARING AID TRAIL WITH APPROPRIATELY FITTED HEARING AIDS; 4)LACK OF BENEFIT FROM APPROPRIATELY FITTING HEARING AIDS. IN YOUNGER CHILDREN, LACK OF BENEFIT WITH HEARING AIDS IS DEFINED AS FAILURE TO ATTAIN BASIC AUDITORY MILESTONES SUCH AS A CHILD'S INCONSISTENT RESPONSE TO HIS/HER NAME IN QUIET OR TO ENVIRONMENTAL SOUNDS (MEANINGFUL AUDITORY INTEGRATION SCALE). IN OLDER CHILDREN, LACK OF AIDED BENEFIT IS DEFINED AS SCORING 0% ON OPEN-SET WORD RECOGNITION (PHONETICALLY BALANCED KINDERGARTEN TEST - WORD LIST) ADMINISTERED WITH MONITORED LIVE-VOICE (70 DB SPL). BOTH YOUNGER AND OLDER CHILDREN SHOULD DEMONSTRATE ONLY MINIMAL ABILITY ON AGE APPROPRIATE OPEN-SET SENTENCE MEASURES AND A PLATEAU IN AUDITORY DEVELOPMENT.
Regulatory pathway
Original PMA
Clinical specialty
Ear, Nose, Throat
Decision date
Jun 26, 1997

FDA source record

Regulatory record facts

Identifier
P960058
Regulatory pathway
Premarket approval application
Product code
MCM
Decision code
APPR
Decision date
Jun 26, 1997
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, cochlear.

Product code
MCM
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P960058 received

    Application receipt date recorded by FDA.

  2. P960058 · FDA decision

    APPR

  3. P960058/S177 · Related supplement

    HiResolution Bionic Ear System

  4. P960058/S178 · Related supplement

    CLARION MULTI-STRATEGY COCHLEAR IMPLANT

Timeline entries are records held by MedtechLedger for P960058. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960058

Product / regulatory recordCompanyPathwayDecision dateSource
Advanced BionicsPMA supplementSep 4, 2026FDA
Advanced BionicsPMA supplementSep 18, 2026FDA

Explore the linked device profile

Other records with product code MCM

Product / regulatory recordCompanyPathwayDecision dateSource
Med-El Corp.PMA supplementOct 9, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Med-El Corp.PMA approvalAug 20, 2001FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Advanced Bionics

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
28515 Westinghouse Pl., Valencia, CA, 91355

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records